Why the study?
Is aspirin less effective at inhibiting platelet aggregation in women compared with men who have a history of ischemic stroke or TIA?
Is aspirin less effective at inhibiting platelet aggregation in women compared with men who have a history of ischemic stroke or TIA?
Aspirin may have reduced antiplatelet efficacy in women compared to men for secondary prevention after ischemic stroke or TIA.
May warrant sex-specific antiplatelet considerations post-stroke; leaves open confirmation in randomized outcome trials.
Our data suggest that aspirin may be less effective at inhibiting platelet aggregation in women compared with men who have a history of ischemic stroke or TIA.
No takes yet. Share an insight, caveat, or question.
Cavallari et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: